United Therapeutics (UTHR) Stock Chart & Stock Price History $309.22 +3.84 (+1.26%) Closing price 04:00 PM EasternExtended Trading$298.25 -10.97 (-3.55%) As of 05:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock United Therapeutics Stock Price Performance The United Therapeutics (UTHR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 10.80%, with a year-to-date return of -12.36%. In the past month, the stock has increased 1.55%, reflecting recent market activity. As of the latest close, United Therapeutics traded at $305.38 with a market cap of $13.77 billion and volume of 659,907 shares. Five years ago, the stock traded at $105.04, representing a 194.38% increase over that period. At the time, it had a market cap of $4.66 billion and a volume of 282,876 shares. Receive UTHR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.46%1 Month Performance+1.55%3 Month Performance+0.51%Year-To-Date Performance-12.36%1 Year Performance-10.80%5 Year Performance+194.38% UTHR Stock Chart for Tuesday, August, 26, 2025 UTHR Chart by TradingView United Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025$312.23$305.38-2.19%$312.65$304.84659,907 shs$13.77 billion08/22/2025$310.66$312.23+0.51%$315.73$308.26576,473 shs$14.08 billion08/21/2025$306.48$310.66+1.36%$311.37$303.59546,937 shs$14.01 billion08/20/2025$313.22$306.48-2.15%$314.98$306.01685,040 shs$13.83 billion08/19/2025$314.10$313.22-0.28%$317.31$311.36543,291 shs$14.13 billion08/18/2025$313.13$314.10+0.31%$316.21$311.55651,683 shs$14.17 billion08/15/2025$312.06$313.13+0.34%$314.24$310.61703,795 shs$14.13 billion08/14/2025$309.72$312.06+0.76%$312.48$305.00586,994 shs$14.08 billion08/13/2025$301.39$309.72+2.76%$310.07$301.30579,471 shs$13.97 billion08/12/2025$300.43$301.39+0.32%$302.68$292.34883,716 shs$13.55 billion Get the Latest News and Ratings for UTHR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025$301.50$300.43-0.35%$306.00$300.24575,733 shs$13.55 billion08/08/2025$299.42$301.50+0.69%$305.36$297.38519,284 shs$13.60 billion08/07/2025$302.41$299.42-0.99%$304.77$296.57520,163 shs$13.51 billion08/06/2025$304.81$302.41-0.79%$307.06$299.45540,914 shs$13.64 billion08/05/2025$292.65$304.81+4.16%$307.49$291.221.14 million shs$13.75 billion08/04/2025$294.28$292.65-0.55%$294.34$287.64909,297 shs$13.20 billion08/01/2025$274.70$294.28+7.13%$296.60$283.012.43 million shs$13.27 billion07/31/2025$281.95$274.70-2.57%$284.00$272.12640,991 shs$12.39 billion07/30/2025$297.56$281.95-5.25%$300.49$280.351.02 million shs$12.72 billion07/29/2025$298.14$297.56-0.19%$302.14$296.85527,065 shs$13.42 billion07/28/2025$304.50$298.14-2.09%$306.24$297.30497,311 shs$13.45 billion07/25/2025$306.41$304.50-0.62%$307.27$302.11310,921 shs$13.74 billion Related Companies BIIB Stock Price Chart INCY Stock Price Chart NBIX Stock Price Chart BMRN Stock Price Chart EXEL Stock Price Chart MDGL Stock Price Chart EXAS Stock Price Chart HALO Stock Price Chart RGEN Stock Price Chart IONS Stock Price Chart Receive UTHR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:UTHR) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access